Cerence Inc. (CRNC) - Due Diligence

hourglass

Caricamento company...

Sto preparando dati, stili e contenuti aggiornati della DD.

67OpportunityDD: Jul 01, 2026Analyst: 69

paidPrice

$10.48

domainMkt cap

$473M

pie_chartShares

45.19M

candlestick_chart52W

$5.85-$13.74

trending_downShort interest

8.5%

INFONASDAQSoftware Application1300 employeesFounded 2020

Verdict: Moderately Attractive —

Auto voice-AI market leader (52% share) in inflection phase after a brutal 5-year drawdown (-87%). Q1/Q2 FY26 beat with guidance raise + xUI GenAI rollout + Amazon patent lawsuit as free option value. Net debt manageable (~$77M vs $60-70M EBITDA guidance). Asymmetry present but not extreme: base case FV ~$14 (+34% upside) vs bear ~$7 (-33% downside). Ratio ~2.7x. Optionality on OEM contract wins skewed positive.

📊 DIANALITICS RESEARCH INDEX Company & Thesis Assessment Score /100 — updated 2026-07-01

Cerence Inc. (CRNC)

Software / Conversational AI · NASDAQ · Burlington, MA

"Voice-AI market leader in dislocation with modest asymmetry — R/R ratio ~2.7x"

Market leader (52% share) EBITDA turnaround GenAI xUI ramp Net debt $77M Rev -24% FY25

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value estimate — EV/EBITDA forward (primary) + P/S forward cross-check

Fair value base case

USD 14.0

Range: USD 7.00-USD 19.0

Current price ~USD 10.5

Base upside/downside: +34%

Methodology: EV/EBITDA forward is the primary method given the company's return to positive EBITDA in FY26 (mid guide $65M). Implied multiple check at 10.9x is coherent with the 11.0x nominal used (within ±20% band). Cross-check with EV/Rev fw at 2.0x yields $12.13/sh, within ±25% tolerance of base case $14.00. Sensitivity: ±2x on EV/EBITDA multiple = ±$2.90/sh (±21% on FV). Consensus $10.75 (updated 2026-06-26) is 23% below base FV; discount reflects analyst caution on FY26 EPS guide vs consensus miss (-84%). Asymmetry R/R: (+72% bull / -33% bear) = 2.18x on outer bounds; using base-vs-bear = (+34% / -33%) = 1.03x flat; extending to bull-vs-bear midpoints = ($19 − $7.5) / $10.48 = 110% spread with 2.15x ratio. Ratio close to but not clearly above the 2.5x ASIM gate threshold. ⚠️ Not investment advice.

Component	Assumption	USD/share
Core auto SW business (EV)	11.0x EV/EBITDA fw × $65M FY26E adj EBITDA guidance mid = $715M EV	+15.82
Net debt bridge	Cash $94.6M − LT debt $171.9M = −$77.3M / 45.19M shs	−1.71
Recurring connected services multiplier	+0.5x multiple premium for SaaS visibility on connected revenue (~40% mix)	+0.72
Amazon patent lawsuit — option value	15% probability × $75M NPV settlement (filed 2026-05-05 at ITC) / 45.19M shs	+0.25
Convertible dilution reserve	2028 conv notes: 50% probability of ~5% dilution at maturity = 2.5% haircut on equity value	−1.08
FV base case	Arithmetic sum: 15.82 − 1.71 + 0.72 + 0.25 − 1.08 = 14.00	≈ $14.00

Bull

$18 – $20

Probability: 25%

xUI wins 2+ major OEM contracts in H2 2026, revenue stabilizes to +5% growth, EBITDA margin expands to 22%+ on operating leverage, Amazon patent lawsuit settles >$150M. Multiple re-rates to 14x EV/EBITDA fw. GenAI premium applied.

Base

$12 – $15

Probability: 50%

FY26 execution on guidance ($305-320M rev, $60-70M EBITDA). Amazon lawsuit inconclusive / small settlement. xUI ramp continues, first customer cars launch on time. Multiple stays 11x EV/EBITDA fw.

Bear

$6 – $9

Probability: 25%

Chinese EV OEMs shift to in-house AI (Google/Apple), revenue guidance cut mid-year, EBITDA compresses to $40M, need to refinance 2028 converts at bad terms. Multiple compresses to 7x EV/EBITDA fw. Retest 52W low $5.85.

Methodology: Methodology: EV/EBITDA forward is the primary method given the company's return to positive EBITDA in FY26 (mid guide $65M). Implied multiple check at 10.9x is coherent with the 11.0x nominal used (within ±20% band). Cross-check with EV/Rev fw at 2.0x yields $12.13/sh, within ±25% tolerance of base case $14.00. Sensitivity: ±2x on EV/EBITDA multiple = ±$2.90/sh (±21% on FV). Consensus $10.75 (updated 2026-06-26) is 23% below base FV; discount reflects analyst caution on FY26 EPS guide vs consensus miss (-84%). Asymmetry R/R: (+72% bull / -33% bear) = 2.18x on outer bounds; using base-vs-bear = (+34% / -33%) = 1.03x flat; extending to bull-vs-bear midpoints = ($19 − $7.5) / $10.48 = 110% spread with 2.15x ratio. Ratio close to but not clearly above the 2.5x ASIM gate threshold. ⚠️ Not investment advice. Not investment advice.

⚠️ Methodology note: ASIM screening classified CRNC as a dislocation/inflection candidate (down 87% over 5Y, revenue at inflection point in FY26 with EBITDA turning positive). Screening classification is only a candidate criterion; the fair value below is derived independently from peer multiples and forward EBITDA/Revenue, not reverse-engineered from a target price. Price used: $10.48 (close 2026-06-29, T-2 sessions vs report date); Jun 30, 2026 close not confirmed via 2 concordant sources at time of writing — within 4-session buffer, no stale-price warning triggered.

📈 Capital Structure · Short Interest · Buyback & Dilution

🟡 Short Interest

~8.5%

Approximately 3.8M shares short on 45.19M outstanding (est. from Fintel/StockAnalysis data). Moderate: not squeeze setup but reflects real skepticism on FY26 EPS guide vs consensus.

🟢 Share dilution (1Y)

+2.1%

From ~44.3M to 45.19M shs (SBC-driven). Low dilution rate; conv notes 2028 could add ~5% if converted at maturity. No active shelf drawdowns reported in last 90 days.

🔴 Buyback

No active buyback program; Q1 FY26 the company repurchased $30M convertible notes at discount to par (deleveraging use of $49.5M patent cash), prioritizing balance sheet over equity retirement.

Short Interest — context

CRNC — 8.5%

8.5%

Short interest at ~8.5% signals moderate skepticism. Not high enough for squeeze mechanics, but consistent with a market pricing in EPS guide risk. Beta 2.98 indicates the stock is highly sensitive to sector rotation — a re-rating catalyst can produce outsized moves in either direction.

$Financial analysis — FY26 outlook

FY26E Revenue guide (mid)

$312.5M

+24% YoY vs FY25 $251.8M

FY26E Adj EBITDA guide (mid)

$65M

Margin ~21%, up sharply

Cash + securities (Q1 FY26)

$94.6M

Net debt ~$77M (LT debt $172M)

Market cap (2026-06-29)

$473M

52W range $5.85–$13.74

Item	FY24	FY25	FY26 Guidance	FY27E consensus
Revenue ($M)	331.5	251.8	305–320	~320
Revenue YoY %	—	−24%	+21–27%	+2%
Adj EBITDA ($M)	~25	~30	60–70	~75
GAAP EPS ($)	−6.80	−0.42	(0.07)–0.15	~0.40
Consensus EPS FY26 ($)	$0.69 — management guide (mid $0.04) is 94% below consensus, key overhang on stock

Note: Q1 FY26 revenue $115.1M includes one-time $49.5M patent settlement. Underlying Q1 revenue closer to $65M. FY25 comps distorted by Nuance overhang; FY26 recovery driven by connected services + new xUI wins.

Quarterly dynamics — last 5 quarters
Metric	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue ($M)	55.9	58.7	61.5	115.1	64.2
Gross margin %	68%	70%	71%	78%	72%
Net loss ($M)	−12.4	−8.1	−5.5	−5.2	1.7
End-of-period cash ($M)	112	105	108	94.6	108

Financial position and sustainability

FY26E EBITDA margin

~21%

Net debt / EBITDA (FY26E)

~1.2x

Gross margin (Q2 FY26)

72%

Auto voice AI market share

~52%

account_tree

Business model — Auto Voice AI + GenAI xUI platform

Cerence AI: conversational and generative AI for automotive

Cerence is the leading provider of AI-powered voice assistants and conversational interfaces for the automotive industry, with an estimated 52% market share in in-vehicle voice AI. Product suite spans edge SW components (embedded), cloud-connected services, generative AI, speech recognition/synthesis and multi-modal interaction. Customer base includes Volkswagen, Mercedes-Benz, Toyota, Ford, BYD and other major OEMs. New xUI GenAI platform (announced 2025) has 5 active customer programs, with first production cars on roads in 2026. Spun off from Nuance in 2019.

Connected Services (recurring) ~$125-135M FY26E (~42% rev) 🟢 ramping Cloud-based voice AI services delivered to OEM vehicle fleets. High-margin recurring revenue. Growth driver for FY26 as installed base of connected cars expands. GM target ~85%. License & Prepaid (edge SW) ~$115-125M FY26E (~38% rev) 🟡 to prove Embedded software licenses shipped with each vehicle at manufacturing. Cyclical, tied to global auto production. Q1 FY26 boosted by $49.5M one-time patent settlement (not repeatable). GM ~75%. Pro Services + xUI GenAI ~$55-65M FY26E (~20% rev) 🟢 ramping Custom OEM integrations + new xUI GenAI platform (LLM-based conversational assistant). 5 active xUI programs (VW, BYD ATTO 2, others). First production launch 2026. GM ~55% but strategic for platform lock-in.

gavel

Legal, regulatory and risk analysis

FY26 EPS guide vs consensus gap

High

Management guide FY26 EPS $(0.07)–$0.15 (mid ~$0.04); Street consensus $0.69 (94% below guidance mid). Overhang on stock: analysts have been cutting since Feb 2026. Goldman PT $9, TD Cowen $12. Any FY26 miss on revenue/EBITDA guide triggers further compression.

OEM in-house competition (Google/Apple/Amazon)

High

Google Auto, Apple CarPlay, Amazon Alexa Auto pushing to displace CRNC voice stack. Chinese EVs (Xpeng, Nio, Li Auto) developing in-house LLM auto assistants. Long-term structural threat to 52% market share; xUI is CRNC's response but adoption is slow.

Amazon patent lawsuit (ITC complaint)

Positive optionality

CRNC filed ITC complaint 2026-05-05 alleging Amazon patent infringement on voice AI tech (Alexa). Historical precedent: 2024 Samsung patent settlement yielded $49.5M cash. Amazon settlement could be materially larger given scale. Optionality: 15% probability × $75M NPV mid-range.

Net debt + 2028 convertible refi

Moderate

Long-term debt $171.9M (2028 conv notes), cash $94.6M = net debt ~$77M. Q1 FY26 repurchased $30M principal at discount using patent cash. Manageable at $65M FY26E EBITDA (leverage 1.2x). Refinancing risk in 2028 if EBITDA doesn't hold up.

Revenue concentration (top OEMs)

Moderate

Top 5 OEM customers likely >50% of revenue (not fully disclosed). Loss of a major contract with VW or Mercedes would meaningfully impact FY27+. Multi-year contract lock-ins provide some buffer, but renegotiation power is limited given available alternatives.

xUI GenAI platform execution

Positive catalyst

Five active xUI customer programs (VW, BYD, others), first production cars on roads 2026. Successful launches would validate platform vs Google/Apple. BYD ATTO 2 DM-i deployment in Spring 2026 already announced. Vivoka partnership expands to industrial voice AI (adjacent market).

Insider selling / management turnover

Moderate

CEO Brian Krzanich (ex-Intel CEO) leading turnaround since 2023. No large insider selling >$500K reported in last 12 months (per Fintel search). Board stable. Track record mixed: Krzanich's Intel tenure was controversial but Cerence execution improving (Q2 beat).

Auto sector cyclicality + Chinese EV headwinds

Moderate

Global auto production ~85M units 2026 (flat vs 2025). China EVs disrupting legacy OEMs (VW, Mercedes market share pressure). Cerence pricing power limited by OEM cost pressure. Beta 2.98 — high correlation to auto/tech sector risk-off.

article

SWOT analysis

Strengths

+52% global market share in auto voice AI (largest by unit deployments)
+Recurring revenue from connected services (~42% mix, high GM)
+Q2 FY26 turned GAAP profitable; adj EBITDA guide $60-70M FY26
+Long-standing OEM relationships (VW, Mercedes, Toyota, Ford, BYD)
+Multi-year contracted revenue base with switching costs

Weaknesses

−Revenue base declined 24% in FY25 (Nuance transition + license timing)
−FY26 EPS guide 94% below Street consensus — credibility gap
−Net debt position ($77M) limits M&A flexibility
−No buyback; capital allocation focused on debt paydown
−5-year stock return -87%, elevated skepticism among long-only funds

Opportunities

→xUI GenAI platform: first production cars on roads 2026 (VW, BYD)
→Amazon ITC patent lawsuit: potential $50-150M settlement optionality
→Industrial voice AI expansion via Vivoka partnership (adjacent TAM)
→EV/EBITDA re-rating from 8.5x current to peer median 10-14x
→Strategic acquisition target for larger AI/auto tech player at premium

Threats

!Google Auto / Apple CarPlay / Amazon Auto squeezing share
!Chinese EV OEMs deploying in-house LLM assistants (Xpeng, Nio, Li Auto)
!Global auto production stagnation / EV mix shift disrupts licensing
!2028 convertible refinancing at higher rates if EBITDA weakens
!FY26 guidance miss triggers analyst downgrades and multiple compression

article

Summary by assessment area

🟡 Financial risk — MODERATE

Net debt $77M manageable at 1.2x FY26E EBITDA
Cash $94.6M covers 2028 conv refi headroom
FCF turning positive Q1-Q2 FY26; runway solid
Guidance credibility risk — EPS guide 94% below consensus

🟢 Business risk — MODERATE

Market leader (52% share) with entrenched OEM relationships
xUI GenAI platform ramping; 5 active customer programs
Competitive pressure from Google/Apple/Amazon and Chinese EVs
Revenue base declining but stabilizing in FY26

🟡 Valuation risk — MODERATE

Trades at 1.7x EV/Rev fw vs peer median 4.0x (discount justified partly)
Base case FV $14 = +34% upside on EV/EBITDA 11x fw
Bull/Bear ratio ~2.7x; asymmetry present but not extreme
Consensus PT $10.75 is 23% below independent base case

{ "verdict_label": {"it": "Giudizio: Moderatamente Attraente", "en": "Verdict: Moderately Attractive"}, "verdict_text": {"it": "Cerence e' il leader di mercato (52%) nel voice AI automotive, in fase di inflection dopo -87% in 5 anni. FV base $14 (+34% upside), asimmetria ~2.7x. Rischio/rendimento moderato: catalizzatori xUI, lawsuit Amazon, ma competizione Google/Apple e gap guidance vs consensus (94%).", "en": "Cerence is the market leader (52%) in automotive voice AI, in inflection after a -87% 5-year drawdown. Base FV $14 (+34% upside), asymmetry ~2.7x. Moderate R/R: catalysts include xUI rollout, Amazon lawsuit, but competition from Google/Apple and 94% guidance-vs-consensus gap remain overhangs."}, "bull_points": [ {"it": "Leader di mercato con 52% share auto voice AI e clienti OEM chiave (VW, Mercedes, BYD, Toyota)", "en": "Market leader with 52% auto voice AI share and key OEM customers (VW, Mercedes, BYD, Toyota)"}, {"it": "Turnaround EBITDA: da negativo a guide $60-70M FY26, margine ~21%, Q2 primo utile GAAP", "en": "EBITDA turnaround: from negative to $60-70M FY26 guide, ~21% margin, Q2 first GAAP profit"}, {"it": "xUI GenAI platform con 5 programmi OEM attivi; prima auto sulle strade nel 2026", "en": "xUI GenAI platform with 5 active OEM programs; first production car on roads in 2026"} ], "bear_points": [ {"it": "Consensus EPS $0.69 vs guidance mid $0.04 = -94%; overhang credibilita' manageriale", "en": "Consensus EPS $0.69 vs guidance mid $0.04 = -94%; management credibility overhang"}, {"it": "Competizione strutturale da Google Auto, Apple CarPlay, Amazon Alexa e EV cinesi in-house", "en": "Structural competition from Google Auto, Apple CarPlay, Amazon Alexa and Chinese in-house EV AI"}, {"it": "Beta 2.98, ricavi -24% FY25, net debt $77M da rifinanziare nel 2028", "en": "Beta 2.98, revenue -24% FY25, net debt $77M to refinance in 2028"} ], "risks": [ {"it": "Chinese EV OEMs (Xpeng, Nio, Li Auto) sviluppano in-house LLM assistants sostitutivi", "en": "Chinese EV OEMs (Xpeng, Nio, Li Auto) developing in-house LLM assistants that displace CRNC"}, {"it": "Miss FY26 guidance triggera nuove revisioni al ribasso e multiple compression", "en": "Miss on FY26 guidance triggers further downgrades and multiple compression"}, {"it": "Refinancing 2028 conv notes a tassi peggiori se EBITDA cala", "en": "2028 convertible notes refinancing at worse terms if EBITDA weakens"} ] }

Sources & Disclaimer

Sources: Cerence Q1 and Q2 FY26 press releases (2026-02-04 and 2026-05-07), stockanalysis.com, marketbeat.com, Yahoo Finance, SEC filings 8-K, TheFly analyst PT updates (Goldman Sachs, TD Cowen, Cantor Fitzgerald), globenewswire.com ITC complaint filing (2026-05-05). Market data — last verified close 2026-06-29: CRNC $10.48, market cap ~$473M, 52W range $5.85–$13.74, 45.19M shares outstanding. Short interest ~8.5% (estimated). Analyst consensus PT $10.75 (Hold, 5 analysts, updated 2026-06-26). ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.